Approved for Treatment of asthma (patients not adequately controlled on ICS alone), Maintenance treatment of COPD. Fluticasone provides anti-inflammatory effects while salmeterol provides long-acting bronchodilation through beta-2 receptor stimulation. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…